ストックスクリーナーアプリを入手
31.86
0.60%
0.19
アフターアワーズ：
32.00
0.14
+0.44%
前日終値:
$31.67
開ける：
$31.72
24時間の取引高:
1.48M
Relative Volume:
1.23
時価総額：
$5.88B
収益：
$797.73M
当期純損益:
$-325.77M
株価収益率:
-17.97
EPS:
-1.7725
ネットキャッシュフロー:
$-332.79M
1週間 パフォーマンス:
-0.31%
1か月 パフォーマンス:
-3.10%
6か月 パフォーマンス:
-6.95%
1年 パフォーマンス:
-27.69%
1日の値動き範囲:
$31.64
$32.37
1週間の範囲:
$31.60
$33.09
52週間の値動き範囲:
$27.34
$47.79
Legend Biotech Corp Adr Stock (LEGN) Company Profile
LEGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LEGN
Legend Biotech Corp Adr
|
31.86 | 5.85B | 797.73M | -325.77M | -332.79M | -1.7725 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-10-08 | 開始されました | Redburn Atlantic | Buy |
| 2024-06-17 | 開始されました | Truist | Buy |
| 2024-05-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-05-23 | 開始されました | Deutsche Bank | Buy |
| 2024-04-17 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2024-04-03 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-03-13 | 開始されました | Raymond James | Outperform |
| 2023-12-19 | 開始されました | Scotiabank | Sector Perform |
| 2023-11-06 | 開始されました | Goldman | Buy |
| 2023-05-25 | 開始されました | William Blair | Mkt Perform |
| 2023-05-22 | 開始されました | Daiwa Securities | Buy |
| 2023-03-29 | 開始されました | H.C. Wainwright | Buy |
| 2023-03-24 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-12-06 | 開始されました | UBS | Buy |
| 2022-11-02 | 開始されました | Evercore ISI | Outperform |
| 2022-11-01 | 開始されました | Cowen | Outperform |
| 2022-10-31 | 開始されました | Guggenheim | Neutral |
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
| 2022-03-15 | 開始されました | Barclays | Overweight |
| 2022-01-31 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-21 | 開始されました | Piper Sandler | Overweight |
| 2021-05-18 | 開始されました | BTIG Research | Buy |
| 2020-07-01 | 開始されました | JP Morgan | Overweight |
| 2020-07-01 | 開始されました | Jefferies | Buy |
| 2020-06-30 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Legend Biotech Corp Adr (LEGN) 最新ニュース
H.C. Wainwright lowers Legend Biotech stock price target to $60 on muted growth By Investing.com - Investing.com South Africa
H.C. Wainwright lowers Legend Biotech stock price target to $60 on muted growth - Investing.com India
Ameritas Advisory Services LLC Makes New $32,000 Investment in Arbor Realty Trust $ABR - Defense World
Free cash flow per share of Legend Biotech Corp. Sponsored ADR – MUN:9LB - TradingView
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives $69.25 Average PT from Analysts - Defense World
Vontobel Holding Ltd. Has $368,000 Holdings in Duolingo, Inc. $DUOL - Defense World
Vontobel Holding Ltd. Sells 1,634 Shares of Wynn Resorts, Limited $WYNN - Defense World
Pagaya Technologies (NASDAQ:PGY) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Vontobel Holding Ltd. Reduces Position in XPO, Inc. $XPO - Defense World
Vontobel Holding Ltd. Cuts Stock Position in Waters Corporation $WAT - Defense World
Vontobel Holding Ltd. Raises Position in Rentokil Initial PLC $RTO - Defense World
Vontobel Holding Ltd. Sells 10,000 Shares of Zeta Global Holdings Corp. $ZETA - Defense World
Bennett Associates Wealth Management Has $523,000 Holdings in JPMorgan Chase & Co. $JPM - Defense World
Northeast Bancorp (NASDAQ:NBN) Receives Buy (B) Rating from Weiss Ratings - Defense World
Analysts Set Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Price Target at $69.25 - Defense World
US FDA adds label warning to J&J’s and Legend Biotech’s cancer therapy By Reuters - Investing.com
JPMorgan Chase & Co. Cuts Legend Biotech (NASDAQ:LEGN) Price Target to $76.00 - Defense World
Mirae Asset Global Investments Co. Ltd. Has $530,000 Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
US FDA adds boxed warning to J&J, Legend Biotech’s cancer therapy By Reuters - Investing.com
Legend Biotech (NASDAQ:LEGN) Research Coverage Started at Cantor Fitzgerald - Defense World
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Public Employees Retirement System of Ohio - Defense World
GAMMA Investing LLC Has $30,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Matthews International Capital Management LLC Has $45.89 Million Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Voya Investment Management LLC Takes Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Harbor Capital Advisors Inc. Grows Stock Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Rhumbline Advisers Buys 391 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Advisors Asset Management Inc. Has $673,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics - MSN
Alliancebernstein L.P. Purchases 32,101 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech stock rating reiterated at Outperform by RBC Capital - Investing.com
Legend Biotech Corporation Sponsored ADR $LEGN Stake Decreased by Cinctive Capital Management LP - MarketBeat
Nomura Holdings Inc. Purchases New Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech at Morgan Stanley Conference: CARVYKTI’s Global Impact - Investing.com
Legend Biotech (NASDAQ:LEGN) Shares Up 5.4%Here's Why - MarketBeat
Legend Biotech Mulling 2nd Listing in HK, Singapore, or London: Wire - AASTOCKS.com
Northern Trust Corp Has $9.73 Million Stake in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Rexel (OTCMKTS:RXLSF) Stock Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
Cantor Fitzgerald Expects Weaker Earnings for Legend Biotech - MarketBeat
Legend Biotech’s SWOT analysis: carvykti success drives stock potential amid challenges - Investing.com India
Nuveen LLC Purchases Shares of 170,186 Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Brokers Issue Forecasts for Legend Biotech FY2025 Earnings - Defense World
Price T Rowe Associates Inc. MD Sells 78,302 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech (NASDAQ:LEGN) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World
Resolute Capital Asset Partners LLC Buys New Stake in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
170,186 Shares in Legend Biotech Corporation Sponsored ADR $LEGN Purchased by Nuveen LLC - Defense World
Legend Biotech (NASDAQ:LEGN) Price Target Raised to $78.00 at JPMorgan Chase & Co. - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives $72.38 Average PT from Brokerages - Defense World
Legend Biotech Corp Adr (LEGN) 財務データ
収益
当期純利益
現金流量
EPS
1.11%
0.29%
大文字化:
|
ボリューム (24 時間):